Francesco Lanfranchi

12.6k total citations
24 papers, 184 citations indexed

About

Francesco Lanfranchi is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Francesco Lanfranchi has authored 24 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Francesco Lanfranchi's work include Prostate Cancer Treatment and Research (5 papers), Long-Term Effects of COVID-19 (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Francesco Lanfranchi is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Long-Term Effects of COVID-19 (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Francesco Lanfranchi collaborates with scholars based in Italy, Australia and Germany. Francesco Lanfranchi's co-authors include Pietro Apostoli, Maria Enrica Gilberti, Luca Rozzini, Simona Catalani, Alessandro Padovani, Matteo Bauckneht, Gianmario Sambuceti, Stefano Raffa, Cecilia Marini and Andrea Pilotto and has published in prestigious journals such as Journal of Clinical Oncology, Neurobiology of Aging and Frontiers in Physiology.

In The Last Decade

Francesco Lanfranchi

20 papers receiving 181 citations

Peers

Countries citing papers authored by Francesco Lanfranchi

Since Specialization

Citations

This map shows the geographic impact of Francesco Lanfranchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Lanfranchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Lanfranchi more than expected).

Fields of papers citing papers by Francesco Lanfranchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Lanfranchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Lanfranchi. The network helps show where Francesco Lanfranchi may publish in the future.

Co-authorship network of co-authors of Francesco Lanfranchi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Lanfranchi. A scholar is included among the top collaborators of Francesco Lanfranchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Lanfranchi. Francesco Lanfranchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis 2025 ·Annals of Nuclear Medicine ·Francesco Lanfranchi, Liliana Belgioia, D. Vita, (unknown), S. Mastrogiovanni, (unknown), (unknown), (unknown), Stefano Raffa, (unknown), Maria Isabella Donegani, Roberto Piva, Mattia Riondato, Michela Marcenaro, Giorgia Timon, Cecilia Marini, Salvina Barra, Gianmario Sambuceti, Matteo Bauckneht	0
2	[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Matteo Bauckneht, (unknown), (unknown), G. Russo, Stefano Raffa, Maria Isabella Donegani, (unknown), (unknown), (unknown), (unknown), Fabiano Bini, Franco Marinozzi, Francesco Lanfranchi, Riccardo Laudicella, Gianmario Sambuceti, Alessandro Stefano	2
3	Prostate cancer risk groups by PSMA-PET PROMISE (PPP): Results from an international multi-center registry study. 2025 ·Journal of Clinical Oncology ·Wolfgang P. Fendler, (unknown), Sebastian Hoberück, Isabel Rauscher, Lena M. Unterrainer, Sazan Rasul, Anders Bjartell, Francesco Lanfranchi, Andrea Di Giorgio, Christian H. Pfob, Timo Soeterik, Karolien Goffin, (unknown), (unknown), Jérémie Calais, Michael S. Hofman, Thomas A. Hope, (unknown), Boris Hadaschik, Kambiz Rahbar, (unknown)	1
4	Updated prostate cancer risk groups by PSMA-PET PROMISE (PPP2): Results from an international multi-centre registry study. 2025 ·Journal of Clinical Oncology ·Wolfgang P. Fendler, (unknown), Sebastian Hoberück, Isabel Rauscher, Lena M. Unterrainer, Sazan Rasul, Anders Bjartell, Francesco Lanfranchi, Andrea Di Giorgio, Christian H. Pfob, Timo Soeterik, Karolien Goffin, (unknown), (unknown), Jérémie Calais, Michael S. Hofman, Thomas A. Hope, (unknown), Boris Hadaschik, Kambiz Rahbar, (unknown)	1
5	Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials 2024 ·Targeted Oncology ·Chiara Ciccarese, Matteo Bauckneht, (unknown), Giuseppe Fornarini, (unknown), Francesco Lanfranchi, Germano Perotti, (unknown), (unknown), Giampaolo Tortora, Lucia Leccisotti, Gianmario Sambuceti, Alessandro Giordano, Orazio Caffo, Roberto Iacovelli	2
6	Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients 2024 ·The Quarterly Journal of Nuclear Medicine and Molecular Imaging ·Stefano Raffa, (unknown), Nicola Girtler, Matteo Pardini, Dario Arnaldi, Beatrice Orso, Maria Isabella Donegani, (unknown), Francesco Lanfranchi, Guido Rovera, Federico Massa, Pietro Mattioli, Gianmario Sambuceti, Matteo Bauckneht, Silvia Morbelli	0
7	The prognostic value of FIGO staging defined by combining MRI and [18F]FDG PET/CT in patients with locally advanced cervical cancer 2023 ·Current Problems in Cancer ·Stefano Raffa, Francesco Lanfranchi, (unknown), (unknown), Michela Marcenaro, (unknown), (unknown), (unknown), Cecilia Marini, Serafina Mammoliti, Alessia Levaggi, Alberto Tagliafico, Gianmario Sambuceti, Salvina Barra, Silvia Morbelli, Liliana Belgioia, Matteo Bauckneht	2
8	Mandatory role of endoplasmic reticulum and its pentose phosphate shunt in the myocardial defense mechanisms against the redox stress induced by anthracyclines 2023 ·Molecular and Cellular Biochemistry ·Gianmario Sambuceti, Vanessa Cossu, (unknown), Eva Bianconi, Sonia Carta, Consuelo Venturi, Sabrina Chiesa, Francesco Lanfranchi, Laura Emionite, Sebastiano Carlone, (unknown), (unknown), (unknown), (unknown), Anna Maria Orengo, Silvia Morbelli, Pietro Ameri, Matteo Bauckneht, Cecilia Marini	5
9	Delayed onset Bickerstaff brainstem encephalitis overlapping Miller-Fisher Syndrome during SARS-CoV-2 infection 2023 ·Neurological Sciences ·(unknown), (unknown), Francesco Lanfranchi, Silvia Montella, Raffaele Scala, Maria Lieto, (unknown), (unknown)	0
10	Clinical and Diagnostic Findings of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in the COVID-19 Era 2023 ·Ophthalmologica ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Greta Gandolfi, Melvin Sanicas, (unknown), Benedict Michael, Simone Donati, Claudio Azzolini, Francesco Lanfranchi	5
11	Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 2022 ·Annals of Nuclear Medicine ·Matteo Bauckneht, (unknown), (unknown), Alberto Miceli, Maria Isabella Donegani, Cristina Campi, Daniela Schenone, Stefano Raffa, (unknown), Francesco Lanfranchi, Sara Elena Rebuzzi, Elisa Zanardi, (unknown), Cecilia Marini, Giuseppe Fornarini, Silvia Morbelli, Michele Piana, Gianmario Sambuceti	7
12	Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Silvia Morbelli, (unknown), Maria Isabella Donegani, Dario Arnaldi, Matteo Pardini, (unknown), Francesco Lanfranchi, (unknown), Matteo Bauckneht, Alberto Miceli, (unknown), Beatrice Orso, Emanuela Barisione, Luana Benedetti, (unknown), Flavio Nobili	11
13	Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data 2022 ·Neurobiology of Aging ·Federico Massa, Steffen Halbgebauer, Lorenzo Barba, Patrick Oeckl, (unknown), Matteo Bauckneht, Francesco Lanfranchi, Tiziana Vigo, Dario Arnaldi, Matteo Pardini, Silvia Morbelli, A. Chincarini, Henryk Barthel, Markus Otto, Flavio Nobili	6
14	Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB) 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Francesco Lanfranchi, Dario Arnaldi, Alberto Miceli, Pietro Mattioli, (unknown), Stefano Raffa, Maria Isabella Donegani, (unknown), Federico Massa, Matteo Pardini, (unknown), Gianmario Sambuceti, Matteo Bauckneht, Flavio Nobili, Silvia Morbelli	12
15	Frontiers of COVID-19 2022 ·Sasan Adibi, Paul Griffin, Melvin Sanicas, Maryam Rashidi, Francesco Lanfranchi	3
16	The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab 2021 ·Cancers ·Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, (unknown), Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi, Silvia Morbelli	20
17	Spleen Perfusion as an Index of Gender Impact on Sympathetic Nervous System Response to Exercise 2021 ·Frontiers in Physiology ·Francesco Lanfranchi, (unknown), Stefano Raffa, (unknown), Maria Isabella Donegani, Alberto Miceli, (unknown), (unknown), (unknown), Vanessa Cossu, Silvia Morbelli, Matteo Bauckneht, Gianmario Sambuceti, Cecilia Marini	1
18	Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside? 2021 ·Biomolecules ·Cecilia Marini, Vanessa Cossu, Matteo Bauckneht, Francesco Lanfranchi, Stefano Raffa, Anna Maria Orengo, Silvia Ravera, Silvia Bruno, Gianmario Sambuceti	14
19	Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 2018 ·Journal of Alzheimer s Disease ·Luca Rozzini, Francesco Lanfranchi, Andrea Pilotto, Simona Catalani, Maria Enrica Gilberti, (unknown), Pietro Apostoli, Alessandro Padovani	28
20	Free copper in serum: An analytical challenge and its possible applications 2017 ·Journal of Trace Elements in Medicine and Biology ·Simona Catalani, (unknown), Maria Enrica Gilberti, Luca Rozzini, Francesco Lanfranchi, Alessandro Padovani, Pietro Apostoli	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact